Found: 1
Select item for more details and to access through your institution.
OTSUKA PHARMACEUTICAL EUROPE LTD WITHDRAWS ITS APPLICATION FOR AN EXTENSION OF INDICATION FOR ABILIFY (ARIPIPRAZOLE).
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 11, p. 9
- Publication type:
- Article